Perrigo Revenue 2010-2024 | PRGO
Perrigo Annual Revenue (Millions of US $) |
|
---|---|
2023 | $4,656 |
2022 | $4,452 |
2021 | $4,139 |
2020 | $4,088 |
2019 | $3,870 |
2018 | $4,732 |
2017 | $4,946 |
2016 | $5,281 |
2015 | $2,632 |
2015 | $4,227 |
2014 | $3,914 |
2013 | $3,540 |
2012 | $3,173 |
2011 | $2,755 |
2010 | $2,268 |
2009 | $2,006 |
Perrigo Quarterly Revenue (Millions of US $) |
|
---|---|
2024-03-31 | $1,082 |
2023-12-31 | $1,157 |
2023-09-30 | $1,124 |
2023-06-30 | $1,193 |
2023-03-31 | $1,182 |
2022-12-31 | $1,155 |
2022-09-30 | $1,100 |
2022-06-30 | $1,122 |
2022-03-31 | $1,075 |
2021-12-31 | $1,105 |
2021-09-30 | $1,043 |
2021-06-30 | $981 |
2021-03-31 | $1,010 |
2020-12-31 | $1,053 |
2020-09-30 | $1,003 |
2020-06-30 | $949 |
2020-03-31 | $1,083 |
2019-12-31 | $355 |
2019-09-30 | $1,191 |
2019-06-30 | $1,149 |
2019-03-31 | $1,175 |
2018-12-31 | $1,195 |
2018-09-30 | $1,133 |
2018-06-30 | $1,186 |
2018-03-31 | $1,217 |
2017-12-31 | $1,283 |
2017-09-30 | $1,231 |
2017-06-30 | $1,238 |
2017-03-31 | $1,194 |
2016-12-31 | $1,331 |
2016-09-30 | $1,262 |
2016-06-30 | $1,341 |
2016-03-31 | $1,347 |
2015-12-31 | $-1,023 |
2015-09-30 | $1,273 |
2015-06-30 | $1,415 |
2015-03-31 | $967 |
2014-12-31 | $1,072 |
2014-09-30 | $952 |
2014-06-30 | |
2014-03-31 | $1,004 |
2013-12-31 | $979 |
2013-09-30 | $933 |
2013-06-30 | |
2013-03-31 | $920 |
2012-12-31 | $883 |
2012-09-30 | $770 |
2012-06-30 | |
2012-03-31 | $778 |
2011-12-31 | $838 |
2011-09-30 | $725 |
2011-06-30 | |
2011-03-31 | $692 |
2010-12-31 | $718 |
2010-09-30 | $641 |
2010-06-30 | |
2010-03-31 | $538 |
2009-12-31 | $582 |
2009-09-30 | $528 |
2009-06-30 | |
2009-03-31 | $506 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $4.241B | $4.656B |
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $182.557B | 23.90 |
Stryker (SYK) | United States | $125.439B | 30.04 |
Medtronic (MDT) | Ireland | $108.284B | 15.33 |
Boston Scientific (BSX) | United States | $106.687B | 33.98 |
EssilorLuxottica (ESLOY) | France | $99.794B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.125B | 0.00 |
Haleon (HLN) | United Kingdom | $37.397B | 27.30 |
ResMed (RMD) | United States | $31.274B | 29.36 |
Zimmer Biomet Holdings (ZBH) | United States | $24.862B | 15.88 |
Terumo (TRUMY) | Japan | $24.701B | 34.88 |
Koninklijke Philips (PHG) | Netherlands | $24.145B | 18.70 |
Baxter (BAX) | United States | $18.217B | 12.95 |
Insulet (PODD) | United States | $12.294B | 64.55 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.929B | 0.00 |
Demant (WILYY) | Denmark | $10.100B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.650B | 25.02 |
BellRing Brands (BRBR) | United States | $7.607B | 35.63 |
Lantheus Holdings (LNTH) | United States | $5.164B | 12.87 |
Haemonetics (HAE) | United States | $4.736B | 24.22 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Prestige Consumer Healthcare (PBH) | United States | $3.468B | 16.40 |
Envista Holdings (NVST) | United States | $3.236B | 13.35 |
QuidelOrtho (QDEL) | United States | $2.854B | 15.87 |
TG Therapeutics (TGTX) | United States | $2.646B | 74.43 |
Neogen (NEOG) | United States | $2.610B | 25.10 |
Green Thumb Industries (GTBIF) | United States | $2.604B | 51.58 |
ICU Medical (ICUI) | United States | $2.451B | 21.63 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.843B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.686B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.683B | 49.34 |
InMode (INMD) | Israel | $1.537B | 8.17 |
Owens & Minor (OMI) | United States | $1.386B | 12.08 |
AdaptHealth (AHCO) | United States | $1.288B | 9.59 |
Warby Parker (WRBY) | United States | $1.233B | 0.00 |
National Vision Holdings (EYE) | United States | $1.167B | 37.25 |
AtriCure (ATRC) | United States | $0.985B | 0.00 |
MacroGenics (MGNX) | United States | $0.917B | 0.00 |
Canopy Growth (CGC) | Canada | $0.915B | 0.00 |
Evolus (EOLS) | United States | $0.830B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.813B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.710B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.696B | 14.81 |
VAREX IMAGING (VREX) | United States | $0.644B | 15.14 |
Quanterix (QTRX) | United States | $0.631B | 0.00 |
PetIQ (PETQ) | United States | $0.519B | 16.97 |
Valneva SE (VALN) | France | $0.504B | 0.00 |
Jin Medical (ZJYL) | China | $0.494B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.478B | 0.00 |
Biote (BTMD) | United States | $0.452B | 8.67 |
Surmodics (SRDX) | United States | $0.450B | 28.20 |
ZimVie (ZIMV) | United States | $0.419B | 35.77 |
OraSure Technologies (OSUR) | United States | $0.406B | 12.64 |
Aurora Cannabis (ACB) | Canada | $0.350B | 0.00 |
Cerus (CERS) | United States | $0.348B | 0.00 |
Zynex (ZYXI) | United States | $0.341B | 46.65 |
Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.282B | 27.96 |
TriSalus Life Sciences (TLSI) | United States | $0.258B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.248B | 15.33 |
Veru (VERU) | United States | $0.209B | 0.00 |
Omeros (OMER) | United States | $0.205B | 0.00 |
High Tide (HITI) | Canada | $0.190B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.185B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.182B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.173B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.169B | 0.00 |
InterCure (INCR) | Israel | $0.151B | 25.54 |
Eagleford Energy (GRUSF) | United States | $0.140B | 70.42 |
Jushi Holdings (JUSHF) | United States | $0.137B | 0.00 |
FitLife Brands (FTLF) | United States | $0.137B | 22.00 |
Cellectar Biosciences (CLRB) | United States | $0.115B | 0.00 |
Fonar (FONR) | United States | $0.111B | 9.54 |
MariMed (MRMD) | United States | $0.109B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.101B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.098B | 0.00 |
Brainsway (BWAY) | Israel | $0.095B | 0.00 |
Chimerix (CMRX) | United States | $0.087B | 0.00 |
Safety Shot (SHOT) | United States | $0.065B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
Zevia PBC (ZVIA) | United States | $0.061B | 0.00 |
Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.047B | 0.00 |
Apyx Medical (APYX) | United States | $0.047B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
Bright Green (BGXX) | United States | $0.041B | 0.00 |
Modular Medical (MODD) | United States | $0.037B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.42 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.018B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 73.73 |
IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |